arrow
H

Hyunseok Kang

University of California System
H指数:38
被引数:8,048

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Timely Matters: Predictors of Delay in Oral Cavity Cancer Patients Across the Care Continuum

及时性问题:口腔癌患者在整个护理过程中的延迟预测因素

2026-02-270
PRE
Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer

中性粒细胞与淋巴细胞比值以及接受帕博利珠单抗治疗的患者中口咽癌的生存情况

2026-01-010
PRE
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement

放射性碘难治性不可切除或转移性甲状腺癌的再分化疗法:国际甲状腺肿瘤研究组声明

2025-04-300
OAAI
VERSATILE-002: Survival with first-line treatment with PDS0101 therapeutic vaccine and pembrolizumab in HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)

VERSATILE-002:接受PDS0101治疗性疫苗联合帕博利珠单抗作为一线治疗的人乳头瘤病毒16型阳性复发/转移性头颈鳞状细胞癌(HNSCC)患者的生存情况

2024-09-013
PRE
Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
2022-09-021
OA